RNA, 7SL, cytoplasmic 618, pseudogene (RN7SL618P)

**RNA, 7SL, cytoplasmic 618, pseudogene (RN7SL618P)** is a processed pseudogene derived from the 7SL RNA, which is itself part of the signal recognition particle (SRP) ribonucleoprotein complex responsible for targeting secretory proteins to the endoplasmic reticulum in eukaryotic cells[1][6][9][10]. RN7SL618P is found at chromosome location 13q14.3 but, as a pseudogene, it does not encode a functional RNA or protein and lacks canonical promoter and regulatory elements[5][6][12]. While some pseudogenes can produce regulatory RNAs with possible effects on gene expression, there is no evidence to support a defined molecular function, disease association, or druggability for RN7SL618P specifically[1][4][9][8][11]. **Additional notes:** - RN7SL618P is not considered a therapeutic target, receptor, enzyme, transporter, or signaling molecule. - The entry is "incorrect" in the context of therapeutic targeting: it is a pseudogene and not an actionable drug target or receptor[1][5][6][12]. - 7SL RNA pseudogenes are very common in the genome; most are truncated, non-functional copies of the 7SL RNA that arose from reverse transcription events and have diverse, lineage-specific structures[9][10]. - If you require information about the functional 7SL RNA or its role in the SRP pathway, the correct canonical entry would be "Signal recognition particle RNA (7SL RNA)"[3][7]. **In summary:** RN7SL618P is a non-coding, non-functional pseudogene, with no established drug interactions, biomarker relevance, disease associations, or use as a therapeutic target.

Other names

RN7SL618P

None